BioCentury
ARTICLE | Company News

Faes, Pierre Fabre sales and marketing update

July 19, 2010 7:00 AM UTC

Pierre Fabre received non-exclusive rights to market Faes Farma's Bilastine in France and Belgium. Pierre Fabre will co-market the histamine H1 receptor antagonist with Menarini Group (Florence, It...